• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: July 2020

Finance

Seventure’s Health for Life Capital II™ fund qualifies for French government’s financing initiative (“TIBI”) as first and only fund in the microbiome field

July 30, 2020 Microbiome Times

Seventure Partners, a European leader in financing innovation, announcesthat the technical committee of the French government initiative, which was set up to support financing of technology companies, has approved the eligibility of its Health for […]

Editor's Choice

How viruses and bacteria balance each other in the gut microbiome

July 22, 2020 Microbiome Times

The adage “all things in moderation” applies not to just to food and drink, but also to the legions of bacteria inside our guts helping us digest that food and drink. It turns out the […]

Pharma & Human Health

First Published Clinical Trial Using Live Biotherapeutic Candidate In COVID-19 Patients Suggests Role In Improving Outcomes

July 22, 2020 Microbiome Times

ExeGi Pharma LLC, a U.S.-based company focused on developing and commercializing products targeting the human microbiome, including live biotherapeutic products (LBPs), announced today the results of a 70-patient clinical trial evaluating a new biologic drug […]

Pharma & Human Health

Pendulum Therapeutics Announces Clinical Data For Medical Probiotic That Provides The Dietary Management Of Healthy A1C And Blood Glucose Levels

July 22, 2020 Microbiome Times

Pendulum Therapeutics, an evidence-based microbiome company, announced today the publication of their clinical study in the journal BMJ Open Diabetes Research & Care showing the effectiveness of Pendulum’s novel medical probiotic, Pendulum Glucose Control. The […]

Finance

Biose Industrie Raises Eur 30 Million To Strengthen Its Position As The Reference Microbiome Cdmo

July 20, 2020 Microbiome Times

Biose Industrie announced the closing of a €30 million funding round led by Cathay Capital, alongside the company’s management team, banking partners and the Auvergne-Rhône-Alpes region. Thanks to this funding found, Biose Industrie will benefit […]

Video

Brain Gut Microbiota Axis: A Novel Target for Drug Development

July 15, 2020 Ted Dinan

The brain-gut-microbiota axis is viewed as a novel paradigm in neuroscience and it is abundantly evident that the traditional approaches to developing pharmacological strategies for psychiatric illnesses are no longer yielding results.  There has been no […]

Pharma & Human Health

Azitra Awarded U.S. Composition of Matter Patent Covering Engineered Bacterial Strains for Treating Skin Conditions

July 13, 2020 Microbiome Times

–Azitra, Inc., a clinical-stage medical dermatology biotech company addressing serious skin conditions by harnessing the microbiome, announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,702,558 to the Company […]

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
  • Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
    April 3, 2025
  • Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
    March 25, 2025
  • Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis
    March 5, 2025
sign up

Sign up to the Microbiome Times newsletter